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Background and purpose   To try to improve the outcome of our 
TKAs, we started to use the CKS prosthesis. However, in a ret-
rospective analysis this design tended to give worse results. We 
therefore conducted a randomized, controlled trial comparing 
this CKS prosthesis and our standard PFC prosthesis. Because 
many randomized studies between different TKA concepts gen-
erally fail to show superiority of a particular design, we hypoth-
esized that these seemingly similar designs would not lead to any 
difference in clinical outcome.
Patients and methods   82 patients (90 knees) were randomly 
allocated to one or other prosthesis, and 39 CKS prostheses and 
38 PFC prostheses could be followed for mean 5.6 years. No 
patients were lost to follow-up. At each follow-up, patients were 
evaluated clinically and radiographically, and the KSS, WOMAC, 
VAS patient satisfaction scores and VAS for pain were recorded. 
Results   With total Knee Society score (KSS) as primary end-
point, there was a difference in favor of the PFC group at final 
follow-up (p = 0.04). Whereas there was one revision in the PFC 
group, there were 6 revisions in the CKS group (p = 0.1). The 
survival analysis with any reoperation as endpoint showed better 
survival in the PFC group (97% (95% CI: 92–100) for the PFC 
group vs. 79% (95% CI: 66–92) for the CKS group) (p = 0.02). 
Interpretation   Our hypothesis that there would be no dif-
ference in clinical outcome was rejected in this study. The PFC 
system showed excellent results that were comparable to those in 
previous reports. The CKS design had differences that had con-
siderable negative consequences clinically. The relatively poor 
results have discouraged us from using this design.

Although current results of total knee arthroplasty (TKA) are 
relatively good, there is still room for improvement. There is 
constant research and development, with a view to obtain-
ing longer survival rates (Rand et al. 2003, Julin et al. 2010), 
a better range of motion (high-flex TKA) (McCalden et al. 
2009, Choi et al. 2010, Mehin et al. 2010), or a more anatomi-
cal reconstruction of the joint—such as posterior and ante-
rior cruciate ligament retaining designs (Ries 2007, Pritchett 
2011) and gender-specific TKA (Clarke and Hentz 2008, Kim 
et al. 2010). 
We started to use the CKS prosthesis (Stratec Medical, Ober-
dorf, Switzerland), based on previous research at our institu-
tion showing that the natural patella groove does not have an 
isolated lateral orientation (Barink et al. 2006). In contrast to 
our standard prosthesis (PFC; DePuy/Johnson and Johnson, 
Warsaw, IN) with a lateral orientation of the patellar groove, 
the trochlea of the CKS prosthesis is deeper and has a neutral 
direction. However, in a retrospective analysis, after 1 year 
the CKS prosthesis tended to have worse Knee Society scores 
(KSSs) (Brokelman et al. 2004). We decided to compare the 
outcome thoroughly and started a randomized, controlled trial 
between the CKS and the PFC prostheses.
Many randomized studies of TKAs with different bearings 
(Harrington et al. 2009, Rahman et al. 2010), cruciate-retain-
ing or -substituting devices (Kim et al. 2009), gender-specific 
designs (Kim et al. 2010), and high-flex designs (McCalden 
et al. 2009, Choi et al. 2010, Mehin et al. 2010) generally fail 
to show superiority of one of the devices over the other. We 
therefore hypothesized that the seemingly small differences 
in design between the CKS and PFC system would not lead to 
differences in clinical outcome in our study. 
Patients and methods
We designed a randomized, controlled trial with 2 poste-
rior cruciate ligament (PCL) retaining total knee designs. 
The study protocol was approved by the institutional review 
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Helsinki Declaration. The study was registered in the Clini-
calTrials.gov Protocol Registration System (Identifier: NCT 
00228137). All patients who were scheduled to undergo pri-
mary total knee arthroplasty because of osteoarthritis or rheu-
matoid arthritis at the Radboud University Nijmegen Medi-
cal Centre were considered for inclusion and were enrolled 
prospectively. Exclusion criteria were dementia, hemophilia, 
juvenile rheumatoid arthritis, and ligament insufficiency that 
needed a posterior-stabilized or otherwise more constrained 
type of design. Between November 2002 and December 2004, 
87 consecutive patients (95 knees) were assessed for eligibil-
ity. 5 patients (5 knees) were excluded before randomization: 
2 patients refused to participate, 2 patients had hemophilia, 
and 1 patient had dementia.
After written informed consent had been obtained, the knees 
were randomly allocated to 2 groups. 45 knees received a 
press-fit condylar prosthesis (PFC; DePuy/Johnson and John-
son, Warsaw, IN) and 45 knees received a continuum knee 
system prosthesis (CKS; Stratec Medical, Oberdorf, Switzer-
land). Computer-generated randomization with stratification 
for age, co-morbidity, and flexion contracture was performed 
by an independent observer to allocate the patients in equal 
numbers to the 2 groups.
Both cemented designs are PCL-retaining and have a fixed 
polyethelene (PE) insert on a tibial tray with central keel. The 
femoral and tibial components are made of the same mate-
rial (cobalt-chromium-molybdenum and titanium-aluminium-
vanadium alloy, respectively). In contrast to the lateral orien-
tation of the patellar groove in the PFC prosthesis, the trochlea 
of the CKS prosthesis is deeper and has a neutral direction. 
The femoral component of the PFC has a fixation peg in both 
condyles, whereas the CKS design uses one central peg. Fur-
thermore, the CKS prosthesis has a different surface texture 
of the femoral component. Additionally, the PE insert of the 
CKS design has a more prominent and sharp posterior edge 
compared to the PFC design (Figure 1).
Identical surgical techniques were used in the groups accord-
ing to the manuals of the designers. 6 surgeons were involved 
in the study. All procedures were performed by an experienced 
knee surgeon or under the direct supervision of one. A pneu-
matic tourniquet was used for all patients. A medial parapatel-
lar capsular incision was used. No patellas were resurfaced. 
All implants were cemented after pulsed lavage, drying, 
and pressurization of the cement (Surgical Simplex, Stryker 
Howmedica). Continuous passive motion was started on the 
second postoperative day. Thereafter, active range-of-motion 
exercises and walking were started under the supervision of a 
physiotherapist.
Routine follow-up evaluation was scheduled at postopera-
tive intervals of 3 months, 6 months, 1 year, and annually 
thereafter. Preoperative and postoperative review data were 
recorded by a physician assistant who was blinded regarding 
patient allocation. At each follow-up visit, we took anteropos-
terior, lateral, and skyline patellar radiographs, which were 
evaluated according to the guidelines of the Knee Society 
(Ewald 1989). The primary endpoint of the study was the 
between-group difference in total KSS (Insall et al. 1989). 
Pre-specified secondary endpoints to provide supportive evi-
Figure 1. A. Sagittal view of the PFC design (left) and the CKS design 
(right). B. Anterior view of a computer model of the femoral compo-
nents. Notice the lateral orientation of the trochlea in PFC (left) and 
neutral orientation in the CKS component (right). C. Posterior view of 
the tibial and PE insert components. The central posterior edge of the 
CKS insert (right) is relatively sharp compared to the PFC insert (left).
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dence for the primary objective included results on the KSS 
subscores, the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) score (Bellamy et al. 1988), 
range of motion, survival, and patient satisfaction and pain, 
both of which were assessed using a visual analog scale (VAS; 
0 = total dissatisfaction or no pain and 100 = complete sat-
isfaction or intolerable pain). A reoperation was defined as 
any operative procedure at the involved knee. A revision was 
defined as any removal, exchange, or addition of one or more 
of the prosthetic components.
Statistics
A sample size estimation showed that 37 knees per group 
would be required to detect a clinically relevant difference of 
10 points with a standard deviation of 15 points in the total 
KSS, with an alpha of 0.05 and a power of 80%. Intergroup dif-
ferences were determined using Student’s t-test for continuous 
variables and the Pearson chi-square test or Fisher’s exact test 
for categorical variables. Survival analyses were performed 
using the Kaplan-Meier method and compared using log-rank 
tests. Survival estimates are presented with 95% confidence 
intervals (CIs). For all data sets, differences were considered 
statistically significant at p-values < 0.05.
Results
After randomization, 5 patients were excluded because a pos-
terior-stabilized design was needed after routinely sacrificing 
the PCL in cases with a flexion contracture of 25 degrees or 
more (1 in the CKS group and 4 in the PFC group). Because 
bilateral involvement might cause bias, 8 other knees were 
excluded (5 in the CKS group and 3 in the PFC group). No 
patients were lost to follow-up, but 12 relatively elderly 
patients died of unrelated causes. These patients were analyzed 
according to the latest available follow-up. Consequently, we 
analyzed 39 knees with a CKS prosthesis and 38 knees with 
a PFC prosthesis (Table 1 and Figure 2), with a mean follow-
up of 5.6 (1.2–7.7) years (i.e. 5.4 (1.5–7.7) years for the CKS 
group and 5.7 (1.2–7.7) years PFC group). 
Table 1. Patient demographics and baseline clinical status
  PFC group (n = 38)  CKS group (n = 39)
Sex (female/male)  26/12  24/15
Age, years    65 (10; 45–81)    69 (11; 48–88)
Height, cm  169 (9; 154–187)  170 (11; 148–190)
Weight, kg    85 (18; 61–130)    82 (15; 60–120)
BMI     30 (5; 21–45)    28 (4; 21–39)
Diagnosis (OA/RA)  33/5  37/2
ROM, degrees
 Extension    –4 (6; -20 to 0)    –5 (6; -20 to 5)
 Flexion  109 (14; 75–135)  111 (19; 70–140)
 Total ROM  104 (16; 65–125)  106 (20; 70–140)
KSS, points
 Knee    53 (17; 9–95)    51 (17; 15–91)
 Function    37 (20; -5–70)    42 (20; -10–90)
 Total    89 (32; 4–150)    92 (29; 40–177)
WOMAC score, points    54 (13; 25–75)    52 (14; 25–95)
VAS pain    62 (17; 26–90)    55 (17; 20–91)
Assessed for eligibility (87 patients)
Randomized (n = 90)
82 patients / 90 knees
Excluded (5 patients)
 – not meeting inclusion criteria (3)
 – declined to participate (2)
Allocated to PFC group (n = 45)
 – recieved allocated intervention (n = 41)
 – did not recieve allocated intervention 
   (PS design) (n = 4)
Allocated to CKS group (n = 45)
 – recieved allocated intervention (n = 44)
 – did not recieve allocated intervention 
   (PS design) (n = 1)
Lost to follow-up (n = 0)
Discontinued intervention (died; analyzed 
with latest FU) (n = 5)
Excluded from analysis (bilateral cases) (n = 3)
Analyzed (n = 38)
Excluded from analysis (bilateral cases) (n = 5)
Analyzed (n = 39)
Lost to follow-up (n = 0)
Discontinued intervention (died; analyzed 
with latest FU) (n = 7)
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Figure 2. Flow diagram according to the CONSORT guidelines.
With total KSS as primary 
endpoint, there was a difference 
between groups in favor of the 
PFC group at final follow-up (p 
= 0.04) (Table 2). Evaluation 
of the postoperative KSS sub-
scores, WOMAC score, range 
of motion, VAS for patient sat-
isfaction, and VAS for pain all 
tended to be superior for the 
PFC group (Table 2). At final 
follow-up, there were differ-
ences in KSS knee subscore 
(p = 0.04) and VAS satisfaction 
(p = 0.04) in favor of the PFC 
system.
There was 1 revision in the 
PFC group; a thicker polyethyl-
ene insert was placed for insta-
bility. In contrast, there were 6 
revisions in the CKS group: in 
5 patients, the CKS prosthesis 
was removed because of poor 
function and pain and 1 patient 
was treated with arthrolysis and 688  Acta Orthopaedica 2011; 82 (6): 685–691
secondary resurfacing of the patella. During the removal of 
the prostheses, it appeared that all femoral components of 
the failed CKS group were easy to remove, leaving an intact 
cement layer on the bones—indicating inadequate fixation 
between prosthesis and cement. Cultures were positive in 2 of 
the CKS revisions. 8-year survival analysis with revision for 
any reason as endpoint showed 97% (95% CI: 92–100) sur-
vival for the PFC group and 84% (72–96) survival for the CKS 
group (p = 0.05) (Figure 3A). The survival values for aseptic 
revision were 97% (92–100) and 89% (78–99) respectively (p 
= 0.2) (Figure 3B).
2 other patients in the CKS group were reoperated. 1 patient 
developed postoperative arthrofibrosis and was manipulated 
under anesthesia, but the knee remained stiff with 20° fixed 
flexion deformity and 70° of flexion. 1 patient was treated 
postoperative radiographs and no radiolucent line was pro-
gressive; none of these 5 cases were classified as radiographic 
loosening. The skyline patellar radiographs did not show (sub)
luxation of the patella in the PFC group or in the CKS group.
Discussion
Our hypothesis that there would be no difference in clinical 
outcome between the PFC prosthesis and the CKS prosthe-
sis was rejected. With total KSS as primary endpoint, and for 
survival with any reoperation as endpoint, the CKS group 
showed a worse result. With our standard prosthesis, the PFC, 
we found an excellent survival rate of 97% for any revision 
after 8 years. Other authors have recently reported similar 
Table 2. Clinical results
  PFC group (n=38)  CKS group (n=39)  p-value
Revisions (no.)  1  6  0.1 a
Reoperations (no.)  1  8  0.03 a
ROM (deg)
  Extension  -0.8 (4.1; -20–5)  -3.3 (6.9; -20–10)  0.05 b
  Flexion  108 (15; 80–135)  104 (17; 65–140)   0.2 b
  Total ROM  108 (17; 65–135)  100 (21; 45–140]  0.09 b
KSS (points)
  Knee     88 (12; 59–100)     80 (19; 35–100   0.04 b
  Function     65 (27; -20–100)     55 (30; -10–100   0.1 b
  Total  153 (30; 71–200)  135 (43; 40–200)  0.04 b
WOMAC score (points)    20 (16; 0–57)    24 (22; 0–79)  0.3 b
VAS satisfaction    83 (20; 0–100)    71 (27; 0–100)  0.03 b
VAS pain    17 (24; 0–80)    24 (26; 0–70)  0.3 b
Radiolucency (no.)    2    3  1 a
a Fisher exact test and b Student t-test.
with open debridement followed by antibiotics for 6 
months because of a culture-proven deep infection. 4 
years later, there were no signs of infection and the 
knee functioned well. 2 patients (1 in each group) 
developed a hematoma, both of which were treated 
conservatively. There were no thromboembolic com-
plications. The 8-year survival analysis with any 
reoperation as endpoint showed a difference between 
the PFC group and the CKS group (97% (92–100) for 
PFC and 79% (CI: 66–92) for CKS; p = 0.02) (Figure 
4A). The survival values for aseptic reoperation were 
97% (92–100) and 85% (73–97) respectively (p = 
0.08) (Figure 4B).
Analysis of the radiographs at final follow-up 
showed a radiolucency smaller than 2 mm in one 
zone under the tibial component in 2 cases in the 
PFC group and in 3 cases in the CKS group. These 
radiolucent lines were already present in the direct 
Figure 3. Kaplan-Meier survival plots. A. With revision for any reason as endpoint, the PFC group had a survival of 97% (95% CI: 92–100) after 
8 years and the CKS group had a survival of 84% (72–96) (p = 0.05). B. With aseptic revision as endpoint, the PFC group had a survival of 97% 
(92–100) after 8 years and the CKS group had a survival of 89% (78–99) (p = 0.2).
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10-year survival rates for the PFC prosthesis: 97% survival for 
aseptic loosening (Santini and Raut 2008) and 97% survival 
for revision with any reason other than infection as endpoint 
(Dalury et al. 2008). The functional results of the PFC pros-
thesis in our study were also comparable to those in previous 
reports (Dalury et al. 2008, Harrington et al. 2009, Hanusch 
et al. 2010). 
The excellent clinical scores of the PFC prosthesis do not 
leave a lot of room for improvement, which is probably why 
recent RCTs have failed to show a superior design (Harrington 
et al. 2009, Choi et al. 2010, Rahman et al. 2010). Subtle dif-
ferences in outcome after TKA require more sensitive instru-
ments. It has been reported that patient-based questionnaires 
such as WOMAC and the KSS are subjective and largely 
influenced by pain (Terwee et al. 2006, Stratford and Kennedy 
2006). Objective, functional tests may be a valuable additional 
tool in comparing TKA systems. We have previously shown 
that monitoring of both knee extension velocity and loading 
symmetry during sit-to-stand movements is objective and has 
good discriminative capacity (Boonstra et al. 2008). Similar 
performance-based measurements to quantify functionality 
in TKA patients have been reported by others (Podsiadlo and 
Richardson 1991, Su et al. 1998, Mizner and Snyder-Mackler 
2005).
In addition, we have to realize that the outcome after TKA 
not only depends on the type of implant; Fortin et al. (1999, 
2002) stated that the preoperative status of the patient is the 
strongest determinant of functional outcomes after hip and 
knee surgery, and Noble et al. (2006) and Mahomed et al. 
(2002) emphasized the importance of the expectations of the 
patients. Nevertheless, our study showed an inferior outcome 
with the CKS design. Although different results have been 
published about the CKS prosthesis in the limited amount of 
literature that is available (Martucci et al. 1996, Gobel and 
Schultz 2008), a 79% survival rate for any reoperation after 
8 years in our study is unacceptably low—which made us 
decide to stop further using the CKS implant system.
The question remains as to why we found such a differ-
ence between the PFC and the CKS prostheses, as the designs 
appear to be quite similar. Concerning the articular part of the 
prosthesis, the most prominent difference is the orientation of 
the patella groove. Although patellofemoral complaints are 
one of the complications after TKA, with the highest inci-
dence (1–24%) and an important reason for revision surgery 
(Boyd et al. 1993, Healy et al. 1995, Harwin 1998), it seems 
to be illogical that only a more anatomical trochlea orientation 
in the CKS design would be responsible for a worse outcome.
An important issue is the observation of bad fixation strength 
of the prosthetic components to the bone. It appeared that all 
femoral components of the failed CKS group were easy to 
remove. Only 2 revisions could be attributed to positive bacte-
rial cultures; the other 3 revisions were defined as aseptic loos-
ening after 13, 16, and 51 months. This high rate of aseptic 
loosening is uncommon, especially at this early stage (Bozic 
et al. 2005, Vessely et al. 2006, Schwartz et al. 2010). More-
over, during the removal of the CKS prostheses there was an 
intact cement layer on the bones, indicating inadequate fixa-
tion between the prosthesis and cement. Thus, we believe that 
an important problem of the CKS design is limited cement-
metal interfacial strength of the femoral components.
We therefore wondered what the reason could be for a weak 
cement-metal interface of the CKS components. We analyzed 
the differences in the backside of both designs. The femoral 
component of the PFC has fixation pegs in both condyles, 
whereas the CKS design uses only 1 central peg. 2 pegs 
might enhance the fixation relative to 1 central peg, but to 
Figure 4. Kaplan-Meier survival plots. A. With any reoperation as endpoint, the PFC group had a survival of 97% (95% CI: 92–100) after 8 years 
and the CKS group had a survival of 79% (66–92) (p = 0.02). B. With aseptic reoperation as endpoint, the PFC group had a survival of 97% 
(92–100) after 8 years and the CKS group had a survival of 85% (73–97) (p = 0.08).
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our knowledge this has not been described in the literature. 
We also analyzed the surface roughness of the femoral com-
ponents and found that the CKS components had a lower sur-
face roughness value than the PFC design (Ra = 1.3 ± 0.1 µm 
vs. 1.9 ± 0.3µm; p = 0.01). As shown by Walsch et al. (2004) 
and Manley et al. (1985), a lower surface roughness reduces 
fixation strength of the implant-cement interface and may 
explain why the revised CKS components could be removed 
so easily. 
Another difference between the designs concerns the PE 
insert. The CKS design uses a tibial insert with a more promi-
nent and sharp posterior edge compared to the PFC design. 
This sharp edge may come in contact with the PCL, leading to 
damage and subsequent PCL laxity. In a previous study com-
paring the CKS and the PFC prostheses, kinematic analysis 
supported the suspicion that the CKS design has larger AP 
translations than the PFC design (Ploegmakers et al. 2010). 
Although clinical ratings such as the KSS, total WOMAC, 
and VAS did not show any statistically significant difference 
in that study, subscores regarding higher flexion and higher-
demanding activities showed greater limitations in knees with 
a CKS design. Moreover, it has been described that in addi-
tion to AP instability, PCL insufficiency may cause (anterior 
knee) pain and result in malfunction (Waslewski et al. 1998, 
Pagnano et al. 1998). Thus, the worse functional outcome for 
the CKS system that we found may also be explained by PCL 
insufficiency due to in vivo damage of the PCL at the sharp 
posterior edge of the tibial insert.
Our study had some limitations. First, a relatively high 
number of patients (12) died before final follow-up. Even so, 
all the patients were analyzed with the latest available (and 
minimal 1-year) follow-up. Including these patients, the mean 
follow-up was 5.6 years. Furthermore, no patients were lost 
to follow-up. Another possible limitation is the potential bias 
from there being 6 different surgeons involved in this study. 
However, since we are a teaching hospital all procedures were 
performed by—or under direct supervision of—an expe-
rienced knee surgeon and none of the reoperated cases had 
originally been operated by a surgeon with low volume.
One strength of our study was the randomization process 
with stratification for age, flexion contracture, and co-mor-
bidity. Consequently, patient demographics and the baseline 
clinical status of both groups were similar. Thus, we are con-
vinced that the differences in clinical function and survival 
between the groups were caused by the differences in design 
between the CKS and the PFC prostheses. Our study was not 
designed to determine the reason for the worse results of the 
CKS design. We believe that the reason may have been multi-
factorial, and a combination of low fixation strength and pos-
sible PCL insufficiency. Initially, we thought that the CKS 
system was very similar to the PFC system, but the large dif-
ferences in clinical outcome were evident and discouraged us 
from further use of the CKS system. 
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